Study Shows Long-Term Efficacy of Erenumab for Chronic Migraine – Healio

Read article - Quotes Stewart Tepper, professor of neurology, in a feature story about a year-long extension of a previous 12-week double-blind treatment study, which showed sustained efficacy of erenumab for the treatment of chronic migraines. "This year-long, prospective study suggests that erenumab maintains effectiveness, is very well tolerated, and the trial is reassuring in that no new safety concerns emerged," said Tepper, who led the study.